162 related articles for article (PubMed ID: 25948712)
1. Comprehensive Evaluation for Substrate Selectivity of Cynomolgus Monkey Cytochrome P450 2C9, a New Efavirenz Oxidase.
Hosaka S; Murayama N; Satsukawa M; Uehara S; Shimizu M; Iwasaki K; Iwano S; Uno Y; Yamazaki H
Drug Metab Dispos; 2015 Jul; 43(7):1119-22. PubMed ID: 25948712
[TBL] [Abstract][Full Text] [Related]
2. Similar substrate specificity of cynomolgus monkey cytochrome P450 2C19 to reported human P450 2C counterpart enzymes by evaluation of 89 drug clearances.
Hosaka S; Murayama N; Satsukawa M; Uehara S; Shimizu M; Iwasaki K; Iwano S; Uno Y; Yamazaki H
Biopharm Drug Dispos; 2015 Dec; 36(9):636-43. PubMed ID: 26348733
[TBL] [Abstract][Full Text] [Related]
3. In vivo individual variations in pharmacokinetics of efavirenz in cynomolgus monkeys genotyped for cytochrome P450 2C9.
Iwasaki K; Kitsugi Y; Ikeda K; Yoshikawa T; Hosaka S; Uehara S; Uno Y; Utoh M; Yamazaki H
Biopharm Drug Dispos; 2016 Sep; 37(6):379-83. PubMed ID: 27417918
[TBL] [Abstract][Full Text] [Related]
4. Identification of putative substrates for cynomolgus monkey cytochrome P450 2C8 by substrate depletion assays with 22 human P450 substrates and inhibitors.
Hosaka S; Murayama N; Satsukawa M; Uehara S; Shimizu M; Iwasaki K; Iwano S; Uno Y; Yamazaki H
Biopharm Drug Dispos; 2016 Jul; 37(5):310-3. PubMed ID: 26581561
[TBL] [Abstract][Full Text] [Related]
5. Comparison of p450 enzymes between cynomolgus monkeys and humans: p450 identities, protein contents, kinetic parameters, and potential for inhibitory profiles.
Emoto C; Yoda N; Uno Y; Iwasaki K; Umehara K; Kashiyama E; Yamazaki H
Curr Drug Metab; 2013 Feb; 14(2):239-52. PubMed ID: 22963393
[TBL] [Abstract][Full Text] [Related]
6. Efavirenz clearances in vitro and in vivo in six cynomolgus monkeys associated with polymorphic cytochrome P450 2C9 and simulated by individual physiologically based pharmacokinetic models.
Utoh M; Miura T; Kusama T; Uehara S; Shimizu M; Uno Y; Yamazaki H
Biopharm Drug Dispos; 2017 Oct; 38(7):439-442. PubMed ID: 28608515
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of 89 compounds for identification of substrates for cynomolgus monkey CYP2C76, a new bupropion/nifedipine oxidase.
Hosaka S; Murayama N; Satsukawa M; Shimizu M; Uehara S; Fujino H; Iwasaki K; Iwano S; Uno Y; Yamazaki H
Drug Metab Dispos; 2015 Jan; 43(1):27-33. PubMed ID: 25318994
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms of drug-metabolizing cytochrome P450 enzymes in cynomolgus and rhesus monkeys and common marmosets in preclinical studies for humans.
Uno Y; Uehara S; Yamazaki H
Biochem Pharmacol; 2018 Jul; 153():184-195. PubMed ID: 29277691
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphism of cynomolgus and rhesus macaque CYP2C9.
Uno Y; Matsushita A; Murayama N; Yamazaki H
Drug Metab Pharmacokinet; 2015 Feb; 30(1):130-2. PubMed ID: 25760542
[TBL] [Abstract][Full Text] [Related]
10. Cynomolgus monkey cytochrome P450 2C43: cDNA cloning, heterologous expression, purification and characterization.
Mitsuda M; Iwasaki M; Asahi S
J Biochem; 2006 May; 139(5):865-72. PubMed ID: 16751594
[TBL] [Abstract][Full Text] [Related]
11. Characterization of intestinal and hepatic P450 enzymes in cynomolgus monkeys with typical substrates and inhibitors for human P450 enzymes.
Yoda N; Emoto C; Date S; Kondo S; Miyake M; Nakazato S; Umehara K; Kashiyama E
Xenobiotica; 2012 Aug; 42(8):719-30. PubMed ID: 22324396
[TBL] [Abstract][Full Text] [Related]
12. Utility of non-human primates in drug development: Comparison of non-human primate and human drug-metabolizing cytochrome P450 enzymes.
Uno Y; Uehara S; Yamazaki H
Biochem Pharmacol; 2016 Dec; 121():1-7. PubMed ID: 27318253
[TBL] [Abstract][Full Text] [Related]
13. Novel Cytochrome P450 2C119 Enzymes in Cynomolgus and Rhesus Macaques Metabolize Progesterone, Diclofenac, and Omeprazole.
Uno Y; Murayama N; Yamazaki H
Drug Metab Dispos; 2024 Feb; 52(3):266-273. PubMed ID: 38123944
[TBL] [Abstract][Full Text] [Related]
14. Diclofenac hydroxylation in monkeys: efficiency, regioselectivity, and response to inhibitors.
Tang C; Fang Y; Booth-Genthe C; Kuo Y; Kuduk SD; Rushmore TH; Carr BA
Biochem Pharmacol; 2007 Mar; 73(6):880-90. PubMed ID: 17223083
[TBL] [Abstract][Full Text] [Related]
15. Novel Marmoset Cytochrome P450 2C19 in Livers Efficiently Metabolizes Human P450 2C9 and 2C19 Substrates, S-Warfarin, Tolbutamide, Flurbiprofen, and Omeprazole.
Uehara S; Uno Y; Inoue T; Kawano M; Shimizu M; Toda A; Utoh M; Sasaki E; Yamazaki H
Drug Metab Dispos; 2015 Oct; 43(10):1408-16. PubMed ID: 26228688
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 1A1, 2C9, 2C19, and 3A4 Polymorphisms Account for Interindividual Variability of Toxicological Drug Metabolism in Cynomolgus Macaques.
Uno Y; Uehara S; Murayama N; Yamazaki H
Chem Res Toxicol; 2018 Dec; 31(12):1373-1381. PubMed ID: 30412386
[TBL] [Abstract][Full Text] [Related]
17. CYP2C76, a novel cytochrome P450 in cynomolgus monkey, is a major CYP2C in liver, metabolizing tolbutamide and testosterone.
Uno Y; Fujino H; Kito G; Kamataki T; Nagata R
Mol Pharmacol; 2006 Aug; 70(2):477-86. PubMed ID: 16648389
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous Screening of Activities of Five Cytochrome P450 and Four Uridine 5'-Diphospho-glucuronosyltransferase Enzymes in Human Liver Microsomes Using Cocktail Incubation and Liquid Chromatography-Tandem Mass Spectrometry.
Lee B; Ji HK; Lee T; Liu KH
Drug Metab Dispos; 2015 Jul; 43(7):1137-46. PubMed ID: 25904760
[TBL] [Abstract][Full Text] [Related]
19. Newly identified CYP2C93 is a functional enzyme in rhesus monkey, but not in cynomolgus monkey.
Uno Y; Uehara S; Kohara S; Iwasaki K; Nagata R; Fukuzaki K; Utoh M; Murayama N; Yamazaki H
PLoS One; 2011 Feb; 6(2):e16923. PubMed ID: 21347438
[TBL] [Abstract][Full Text] [Related]
20. Macaque cytochromes P450: nomenclature, transcript, gene, genomic structure, and function.
Uno Y; Iwasaki K; Yamazaki H; Nelson DR
Drug Metab Rev; 2011 Aug; 43(3):346-61. PubMed ID: 21303270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]